Lv4
780 积分 2025-03-12 加入
Rational design of selective bispecific EPO-R/CD131 agonists
3天前
已完结
Microsystem technologies for accelerating the discovery and translation of immunotherapies
3天前
已完结
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
3天前
已完结
Recent Progress in Hydrogen Sulfide-Generating Nanomedicines for Cancer Therapy: From Design to In Situ Generation
3天前
已完结
Influence of Precise Polymer Conjugation on Aptamer-Target Binding
3天前
已完结
Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics
3天前
已完结
Trends in gene therapy delivery technologies
5天前
已完结
FDA approves PDE4 inhibitor for IPF
5天前
已关闭
Novartis pays US$12 billion for Avidity’s lead antibody–oligonucleotide drugs
5天前
待确认
皖公网安备34019202002308
